| scholarly article | Q13442814 |
| P356 | DOI | 10.1128/AAC.44.12.3310-3316.2000 |
| P8608 | Fatcat ID | release_vkt2enynmzbltoacr5zriwsdq4 |
| P932 | PMC publication ID | 90198 |
| P698 | PubMed publication ID | 11083633 |
| P50 | author | Jeremy Bruenn | Q50288410 |
| P2093 | author name string | J Dong | |
| R C Patel | |||
| M Edgerton | |||
| S E Koshlukova | |||
| M W Araujo | |||
| P2860 | cites work | Differential Scanning Microcalorimetry Indicates That Human Defensin, HNP-2, Interacts Specifically with Biomembrane Mimetic Systems†,‡ | Q56501840 |
| Mechanism of stimulation of endogenous fermentation in yeast by carbonyl cyanide m-chlorophenylhydrazone | Q57768846 | ||
| A critical comparison of the hemolytic and fungicidal activities of cationic antimicrobial peptides | Q60314981 | ||
| The Cellular Target of Histatin 5 onCandida albicansIs the Energized Mitochondrion | Q60314983 | ||
| Mechanism of target cytolysis by peptide defensins. Target cell metabolic activities, possibly involving endocytosis, are crucial for expression of cytotoxicity | Q67919559 | ||
| Salivary histatin 5: dependence of sequence, chain length, and helical conformation for candidacidal activity | Q68929515 | ||
| Abrogation by glucose of the ATP suppression induced by miconazole in Candida albicans | Q69314167 | ||
| Interactions of Candida albicans Yeast Cells, Germ Tubes and Hyphae with Human Polymorphonuclear Leucocytes in vitro | Q70214056 | ||
| Stabilization of helix by side-chain interactions in histatin-derived peptides: role in candidacidal activity | Q71433553 | ||
| Questions and answers about defensins | Q73948636 | ||
| The relationship between salivary histatin levels and oral yeast carriage | Q74640937 | ||
| Salivary histatin 5 induces non-lytic release of ATP from Candida albicans leading to cell death | Q77926810 | ||
| Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida albicans | Q24297832 | ||
| CFTR regulates outwardly rectifying chloride channels through an autocrine mechanism involving ATP | Q24307520 | ||
| Candidacidal activity of recombinant human salivary histatin-5 and variants | Q24679661 | ||
| Phylogenetic perspectives in innate immunity | Q28144345 | ||
| Cytokine signal transduction | Q28258951 | ||
| CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130 | Q28273498 | ||
| Structure of human salivary histatin 5 in aqueous and nonaqueous solutions | Q32142849 | ||
| Cytolytic P2X purinoceptors. | Q33592245 | ||
| IV. Paneth cell antimicrobial peptides and the biology of the mucosal barrier. | Q33709901 | ||
| Histatin 3-mediated killing of Candida albicans: effect of extracellular salt concentration on binding and internalization | Q33977671 | ||
| In vitro assessment of antifungal therapeutic potential of salivary histatin-5, two variants of histatin-5, and salivary mucin (MUC7) domain 1. | Q33979652 | ||
| Candida infections: an overview | Q34174059 | ||
| Ubiquitous natural antibiotics | Q34339217 | ||
| Paneth cells and innate immunity in the crypt microenvironment | Q34444506 | ||
| Correlation between rhodamine 123 accumulation and azole sensitivity in Candida species: possible role for drug efflux in drug resistance. | Q35122459 | ||
| Studies of the mechanism of human salivary histatin-5 candidacidal activity with histatin-5 variants and azole-sensitive and -resistant Candida species | Q35138571 | ||
| Modulation of the in vitro candidacidal activity of human neutrophil defensins by target cell metabolism and divalent cations | Q35589794 | ||
| Microbicidal cationic proteins of rabbit alveolar macrophages: amino acid composition and functional attributes | Q36443079 | ||
| Anticandidal activity of major human salivary histatins | Q36966811 | ||
| Antimicrobial defensin peptides form voltage-dependent ion-permeable channels in planar lipid bilayer membranes | Q37662088 | ||
| Defensins | Q38146096 | ||
| Candida albicans mutants deficient in respiration are resistant to the small cationic salivary antimicrobial peptide histatin 5. | Q39472812 | ||
| Direct membrane-damaging effect of ketoconazole and tioconazole on Candida albicans demonstrated by bioluminescent assay of ATP | Q39848887 | ||
| Primary site of action of ketoconazole on Candida albicans | Q39857229 | ||
| Physicochemical cell damage in relation to lethal amphotericin B action | Q40285078 | ||
| Defensins: a family of antimicrobial and cytotoxic peptides | Q40388073 | ||
| Oral Candida: clearance, colonization, or candidiasis? | Q40550395 | ||
| Recent research on the biological activity of suramin | Q40857749 | ||
| Hepatocellular ATP-binding cassette protein expression enhances ATP release and autocrine regulation of cell volume | Q41092596 | ||
| Transfer of a gene encoding the anticandidal protein histatin 3 to salivary glands | Q41149024 | ||
| Candidacidal activity of salivary histatins. Identification of a histatin 5-binding protein on Candida albicans | Q42540712 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Candida albicans | Q310443 |
| human neutrophil | Q101405102 | ||
| P304 | page(s) | 3310-3316 | |
| P577 | publication date | 2000-12-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Salivary histatin 5 and human neutrophil defensin 1 kill Candida albicans via shared pathways | |
| P478 | volume | 44 |
| Q39252818 | A novel horse alpha-defensin: gene transcription, recombinant expression and characterization of the structure and function |
| Q74403131 | Adrenomedullin expression in pathogen-challenged oral epithelial cells |
| Q37111268 | Antibody blockade of IL-17 family cytokines in immunity to acute murine oral mucosal candidiasis |
| Q40424835 | Antifungal activity in vitro and in vivo of a salmon protamine peptide and its derived cyclic peptide against Candida albicans |
| Q34684398 | Antimicrobial peptides in the oral environment: expression and function in health and disease. |
| Q34519189 | Antimicrobial peptides: therapeutic potential for the treatment of Candida infections |
| Q36776474 | Bcr1 functions downstream of Ssd1 to mediate antimicrobial peptide resistance in Candida albicans. |
| Q28205819 | Candida albicans Ssa1/2p is the cell envelope binding protein for human salivary histatin 5 |
| Q36898587 | Candida albicans cell wall proteins |
| Q33927464 | Candidacidal activity of synthetic peptides based on the antimicrobial domain of the neutrophil-derived protein, CAP37 |
| Q46460554 | Characterization of the antimicrobial peptide family defensins in the Tasmanian devil (Sarcophilus harrisii), koala (Phascolarctos cinereus), and tammar wallaby (Macropus eugenii). |
| Q34301662 | Distinct antifungal mechanisms: beta-defensins require Candida albicans Ssa1 protein, while Trk1p mediates activity of cysteine-free cationic peptides |
| Q88091233 | Flying under the radar: Histoplasma capsulatum avoidance of innate immune recognition |
| Q82605930 | HNP-3 enhanced the antimicrobial activity of CIP by promoting ATP efflux from P. aeruginosa cells |
| Q40638341 | Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms |
| Q40433088 | Human beta-defensins: differential activity against candidal species and regulation by Candida albicans |
| Q40421383 | IL-17 Receptor Signaling in Oral Epithelial Cells Is Critical for Protection against Oropharyngeal Candidiasis. |
| Q38975008 | ISSLS PRIZE IN CLINICAL SCIENCE 2017: Is infection the possible initiator of disc disease? An insight from proteomic analysis |
| Q39651994 | Internal thiols and reactive oxygen species in candidacidal activity exerted by an N-terminal peptide of human lactoferrin |
| Q38222087 | Interplay between Candida albicans and the antimicrobial peptide armory. |
| Q38760670 | Intracellular Targeting Mechanisms by Antimicrobial Peptides |
| Q91339469 | Iron Chelator Deferasirox Reduces Candida albicans Invasion of Oral Epithelial Cells and Infection Levels in Murine Oropharyngeal Candidiasis |
| Q29871517 | MUC7 20-Mer: investigation of antimicrobial activity, secondary structure, and possible mechanism of antifungal action |
| Q36134856 | Mammalian defensins in the antimicrobial immune response |
| Q34298661 | Masking of β(1-3)-glucan in the cell wall of Candida albicans from detection by innate immune cells depends on phosphatidylserine. |
| Q35163819 | Molecular targeted treatments for fungal infections: the role of drug combinations |
| Q38240717 | Moonlighting proteins as virulence factors of pathogenic fungi, parasitic protozoa and multicellular parasites |
| Q35057902 | New mechanism of oral immunity to mucosal candidiasis in hyper-IgE syndrome |
| Q33958720 | Oral health promotion interventions on oral yeast in hospitalised and medically compromised patients: a systematic review. |
| Q33700825 | Perspectives for clinical use of engineered human host defense antimicrobial peptides |
| Q33849225 | Potent in vitro and in vivo antifungal activity of a small molecule host defense peptide mimic through a membrane-active mechanism |
| Q38079168 | Properties and mechanisms of action of naturally occurring antifungal peptides |
| Q37594974 | Regulation of fungal infection by a combination of amphotericin B and peptide 2, a lactoferrin peptide that activates neutrophils |
| Q33339288 | SSD1 is integral to host defense peptide resistance in Candida albicans |
| Q34528899 | Salivary histatin 5 and its similarities to the other antimicrobial proteins in human saliva |
| Q38802524 | Sequential and Structural Aspects of Antifungal Peptides from Animals, Bacteria and Fungi Based on Bioinformatics Tools |
| Q37106755 | Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis |
| Q41342515 | The capsule sensitizes Streptococcus pneumoniae to alpha-defensins human neutrophil proteins 1 to 3. |
| Q33952105 | The human salivary peptide histatin 5 exerts its antifungal activity through the formation of reactive oxygen species |
| Q34205894 | The novel Candida albicans transporter Dur31 Is a multi-stage pathogenicity factor |
| Q40730220 | The role of released ATP in killing Candida albicans and other extracellular microbial pathogens by cationic peptides |
Search more.